DegenRx B.V.
PrivateLast Round
Grant
Jun 4, 2019
Company Overview
DegenRx B.V. is a biotechnology company developing AAV-mediated gene therapy for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DegenRx B.V. Comparables
Compare DegenRx B.V. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AviadoBio | 84% | |
| Klogene Therapeutics, Inc. | 83% | |
| Capsida Biotherapeutics | 76% | |
DegenRx B.V. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 4, 2019 | ||||
| Series A | Dec 21, 2018 |
DegenRx B.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Swanbridge Capital | Series A |
| BOM Brabant Ventures | Series A |
| Health~Holland | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2019
Received grant funding from Health~Holland.
- Dec 21, 2018
Raised Series A with BOM Brabant Ventures and Swanbridge Capital.
DegenRx B.V. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DegenRx B.V.'s valuation, stock price, and market status.